NPI: 1922062066 · PUYALLUP, WA 98373 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/14/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/14/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,840 | $315K |
| 2019 | 22,334 | $351K |
| 2020 | 25,728 | $678K |
| 2021 | 23,425 | $589K |
| 2022 | 22,659 | $701K |
| 2023 | 11,133 | $921K |
| 2024 | 6,566 | $853K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 53,339 | 3,521 | $4.08M |
| A4657 | Syringe, with or without needle, each | 3,231 | 2,057 | $240K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 37,353 | 1,975 | $59K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 818 | 429 | $26K |
| J1756 | Injection, iron sucrose, 1 mg | 10,251 | 2,260 | $6K |
| 90747 | 15 | 12 | $489.80 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 14,309 | 1,027 | $470.65 |
| 90674 | 87 | 73 | $188.32 | |
| G0008 | Administration of influenza virus vaccine | 93 | 81 | $79.68 |
| 0011A | 13 | 12 | $33.88 | |
| 85041 | 2,140 | 1,548 | $0.00 | |
| 85048 | 2,111 | 1,527 | $0.00 | |
| 83970 | 1,711 | 1,237 | $0.00 | |
| 83540 | 1,024 | 737 | $0.00 | |
| 82108 | 587 | 426 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 70 | 24 | $0.00 |
| 83550 | 912 | 664 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 596 | 442 | $0.00 |
| 82728 | 960 | 699 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,050 | 550 | $0.00 |
| 86706 | 15 | 12 | $0.00 |